UpToDate vs Medscape
Medscape vs UpToDate cost, depth and which one to keep
Most clinicians weighing UpToDate against Medscape are really asking a budget question: is the paid reference worth keeping when a free one covers so much of the same ground? It is a fair question, and the answer turns on what you use a reference for.
UpToDate sells depth and editorial grading. Its topics are written by named physician authors, reviewed, and given explicit strength-of-recommendation grades, which is what you lean on when a decision has to be defended. Medscape sells breadth at no cost: a solid drug reference, an interaction checker, a pill identifier, clinical news and free CME, all supported by advertising. This page compares them honestly on cost, depth and workflow, and it is candid about the moment both leave uncovered, which is the safety check on the prescription in front of you.
Press Run check for the interaction, contraindication, dosing and alternatives on this pair.
Not matched, so not checked: .
Nothing on this pair matched a row in the reference tables behind this check. That is not a clearance: it means these references do not name this combination.
Guideline-based alternatives
That was your demo check, run on the same references the desk uses. The desk adds renal dosing against an estimated clearance, hepatic review, unlimited checks, saved history and your sign-off on every card.
The on-page check covers five prescribing scenarios and never invents clinical output, so it will not produce a card for this pair.
The full Prescriber.io desk checks any regimen against interactions, contraindications, and renal or hepatic dosing, with cited sources for you to verify.
Interaction
Contraindication / allergy check
Dosing guidance (renal / hepatic)
Guideline-based alternatives
Decision support. You verify against official sources and sign.
Clinician in the loopDecision support for licensed clinicians. Prescriber.io does not diagnose or prescribe and is not a substitute for professional clinical judgment.
Check · flag · suggest · you review and sign off
Prices in detail: UpToDate subscription cost · UpToDate monthly subscription · Medscape cost
The short answer
UpToDate vs Medscape, in brief
Medscape vs UpToDate comes down to free breadth against paid, graded depth. UpToDate is a paid clinical reference whose topics are written and graded by physician authors, and Wolters Kluwer publishes no individual price for it, quoting it only after a country and role selection. Medscape is free with registration and funded by advertising, offering a drug reference, an interaction checker, a pill identifier, medical news and CME. UpToDate is deeper and graded; Medscape is broad, fast and costs nothing. Neither runs the interaction, contraindication and renal or hepatic dose checks together at the second you sign a prescription, which is the point-of-care gap Prescriber.io is built to close.
Side by side
UpToDate vs Medscape vs Prescriber.io
All three are capable tools built for different moments. Here is where they differ, including where we are not the answer.
| What matters | UpToDate | Medscape | Prescriber.io |
|---|---|---|---|
| What it is | Editorially written clinical reference, topics authored and graded by physician editors | Free clinical reference with drug database, interaction checker, pill ID, news and CME | Point-of-care decision-support card for the prescription you are about to sign |
| Cost (individual, October 2026) | No published individual price; quoted by country and role. Billed every 30 or 90 days, or for 1, 2 or 3 years | Free with registration, funded by advertising | From $24 per clinician per month, billed annually |
| Editorial model | Named physician authors write, review and grade recommendations | Editorial staff and contributors, updated content, no formal recommendation grades | Flags cite clinical pharmacology references you confirm yourself |
| Drug interaction checking | Through the integrated drug database (Lexidrug, formerly Lexicomp) | Free multi-drug interaction checker, run as a separate step | Runs automatically on the scenario you enter, with the other checks |
| Contraindications and allergy flags | Covered inside the topic content | Present in the drug monographs | Surfaced in the same card as the interaction check |
| Renal and hepatic dose adjustment | Present in the drug content, looked up per drug | Present in the drug monographs, looked up per drug | Surfaced alongside the interaction and contraindication flags |
| Advertising | No advertising; you pay for it | Ad-supported, including sponsored content | No advertising in the decision-support card |
| Best suited for | A graded recommendation you can cite and defend | Fast, free lookups and staying current at no cost | The prescribing moment, when several checks must happen at once |
Competitor details reflect publicly published information as of October 2026. Products and prices change, so confirm current details with each vendor.
Which one, for whom
Pick the tool that matches the job
Choose UpToDate if
You want a recommendation that has been edited and graded, and you expect to cite or defend it. Residents lean on its topic reviews to learn a condition end to end, and many hospitals already license it, so check whether you can access it at work before paying personally.
Choose Medscape if
You want a capable reference that costs nothing. The drug database, interaction checker and pill identifier cover most everyday lookups, the news keeps you current, and the free CME is a real perk. The trade-off is advertising and the absence of formal recommendation grades, which some clinicians accept happily and others do not.
Add Prescriber.io if
The bottleneck is the check, not the reading. Enter the scenario once and interactions, contraindications, renal and hepatic dose adjustments and guideline alternatives arrive together in one card with cited sources. You review each flag, verify against official sources, and sign.
Is Medscape as good as UpToDate?
For quick facts, Medscape holds its own, and it is free. The drug monographs, interaction checker and disease references are maintained and cover the ground most clinicians need for a fast lookup. Where UpToDate pulls ahead is the editorial layer: its topics carry explicit strength-of-recommendation grades and are written by named physician authors who argue the evidence before you read it. Medscape gives you good reference content; UpToDate gives you a graded position.
So the honest answer is that they are not the same product at different prices. Medscape is a free reference and news platform. UpToDate is a paid editorial operation you buy for the decisions you have to justify. Plenty of clinicians use Medscape for speed and reach for UpToDate, or a colleague who has it, when the decision is heavier.
Is Medscape really free?
Yes. The Medscape app and website are free with registration, and the drug reference, interaction checker, pill identifier, news and CME do not sit behind a paywall. It is funded by advertising, including sponsored content aimed at a clinical audience, which is how a free tool at that scale pays for itself.
The thing to weigh is not a hidden fee but the ad-supported model itself. Promotional content shares the page with reference content, and clinicians differ on how much that matters to them. If it bothers you, a paid reference removes the question. If it does not, the free access is genuine and worth having on your phone.
We re-read both price positions in October 2026. Medscape is still a free download on the US App Store, with no paid tier behind it. The UpToDate store still shows no dollar figure until you choose a country, a role and a profession, and then asks you to sign in. That is why the real comparison is $0 against a number you have to request. If the up-front cost is the obstacle, UpToDate also bills every 30 days until you cancel; our UpToDate monthly subscription guide covers how that works and the 5 business day cancellation rule. Before you request it, check whether a hospital or medical library already gives you access, and read what an individual UpToDate subscription is likely to cost and what it includes. If you are pricing Medscape's side for a practice, our Medscape cost page covers what free actually means there.
What neither tool does at the moment you prescribe
Both wait to be asked. To catch a problem with the script in front of you, you have to think to run the interaction check, then think to check the contraindication, then think about the renal dose, then think about whether a safer agent exists. Four questions, four separate lookups, on an afternoon already running behind. The checks that get skipped are the ones nobody thought to run.
Prescriber.io collapses that into one step. Enter the drug or the scenario and it checks interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives, together, with sources cited on each flag. It is decision-support for licensed clinicians, not autonomous prescribing: you review every flag, verify against official sources, and sign.
See the check run on a scenario of your own
Interactions, contraindications, renal and hepatic dosing and guideline alternatives, in one card you review and sign off on.
Good questions
UpToDate vs Medscape, answered
Keep comparing
Other comparisons clinicians read
UpToDate vs OpenEvidence
OpenEvidence vs UpToDate: OpenEvidence is free for verified US clinicians, UpToDate is paid with no public price. Sources, CME and which one to use.
CompareUpToDate vs Epocrates
Epocrates vs UpToDate: epocrates+ is $179.99 a year or $24.99 a month, UpToDate publishes no price at all. Which one to keep if you pay for only one.
CompareUpToDate vs DynaMed
UpToDate vs DynaMed for a US clinician: DynaMedex lists $599 a year, UpToDate publishes no price. Evidence grades, Micromedex drug content, the ACP route, verdict.
CompareEpocrates vs Lexicomp
Epocrates vs Lexicomp: epocrates+ is $179.99 a year, Lexicomp (now UpToDate Lexidrug) is $29.99 a month on the app. Depth, dental use and which to buy.
CompareEpocrates vs Medscape
Epocrates vs Medscape: Medscape is free with no in-app purchases, epocrates+ is $179.99 a year or $24.99 a month. What the paid tier adds, which app to keep.
CompareUpToDate vs Lexicomp
Lexicomp vs UpToDate: the Lexicomp (Lexidrug) subscription is $29.99 a month, UpToDate publishes no price. Same vendor, different jobs. Which to buy.
CompareOpenEvidence vs ChatGPT
OpenEvidence vs ChatGPT for Clinicians: both are now free to NPI-verified US clinicians, both offer a BAA and CME. Sources, ads, CME and which to use.
CompareLexicomp vs Micromedex
Micromedex vs Lexicomp (Lexidrug): Lexidrug is $29.99 a month, Micromedex has no public price and needs a hospital login. IV compatibility and which to buy.
CompareUpToDate vs Micromedex
UpToDate vs Micromedex: neither publishes a price, and the Micromedex app only activates with a hospital login. Cost routes, drug depth and which to use.
CompareBMJ Best Practice vs UpToDate
BMJ Best Practice vs UpToDate for US clinicians: BMJ publishes its subscription price by role, UpToDate publishes none. Comorbidities Manager, CME, verdict.
ComparePEPID vs Epocrates
PEPID vs Epocrates on published price: the Emergency Medicine Suite is $299.95 a year, epocrates+ $179.99 or free. What the $120 gap buys an emergency clinician, and which to keep.
Compare5 Minute Clinical Consult vs UpToDate
5 Minute Clinical Consult vs UpToDate: 5MCC costs $99.99 a year with a 14 day trial, UpToDate publishes no price. What each covers and which to buy.
CompareClinicalKey vs UpToDate
ClinicalKey vs UpToDate: ClinicalKey Essentials is $299 a year, UpToDate publishes no price. What each includes and which one to pay for yourself.
CompareEpocrates vs Micromedex
Epocrates vs Micromedex: epocrates+ is $179.99 a year or free, Micromedex has no public price and needs your hospital login. Which drug reference to use.
CompareDynaMed vs OpenEvidence
DynaMed vs OpenEvidence: DynaMedex is $599 a year ($675 with Dyna AI), OpenEvidence is free for verified US clinicians. Evidence grades, drug data, verdict.
vs UpToDateUpToDate alternative
One actionable card at the point of care, not a long article to read.
vs EpocratesEpocrates alternative
Interactions, contraindications and dosing together in one card.
Run the prescribing checks in one card
Whichever reference you keep, the interaction, contraindication and dose checks still have to happen. Prescriber.io runs them together and cites its sources. You review, verify, and sign.
Decision-support for licensed clinicians. Prescriber.io does not diagnose or prescribe autonomously and is not a substitute for professional clinical judgment. Always verify against official sources.